Fontana M, Ambardekar AV, Cappelli F, Cuddy SAM, Davis MK, Garcia-Pavia P, Hanna M, Khouri MG, Masri A, Maurer MS, Obici L, Solomon S, Sperry BW, Tahara N, Waddington-Cruz M, Conrad T, Yang Q, Chen J, Tsimikas S, Gillmore JD. Baseline characteristics of patients with transthyretin amyloid cardiomyopathy in the CARDIO-TTRansform trial of eplontersen. Eur J Heart Fail. 2026 Oct 28; 28(4):807-818.

Horiike A, Wakui H, Sugawara S, Minegishi Y, Tasaka S, Kusumoto S, Sakatani T, Suzuki H, Hosomi Y, Tambo Y, Shimokawa T, Ishida H, Miyauchi E, Naoki K, Fukuhara T, Mura E, Tsurui T, Suzuki R, Iriguchi N, Ishiguro T, Hirasawa Y, Manabe R, Shimokawa M, Ohkuma R, Ariizumi H, Kubota Y, Hamada K, Takenoshita S, Ryu K, Sambe T, Inoue E, Wada S, Yoshimura K, Sagara H, Kobayashi S, Tsunoda T. Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Advanced Non-Small Cell Lung Cancer with =50% PD-L1 Expression: A Nonrandomized Phase II Trial. Clin Cancer Res. 2026 Oct 15; 32(20):4571-4579.

Oser TK, Martens T, Ruedy KJ, Bergford S, Calhoun P, Chang KL, Kramer ES, Klug BA, Anderson RL, Cook BR, Pickering D, Ortega M, Peterson B, Davidson L, Schmid R, Desai ND, Burkett E, Haynes JL, Herman A, Topiwala SM, Bailey R, Oser SM, Cadet NN, Johnson ML, Elkind-Hirsch KE, Beck SE, Castle JR, Beck RW. Continuous Glucose Monitoring in Non-Insulin-Treated Type 2 Diabetes. N Engl J Med. 2026 Oct 29; 395(17):1717-1727.

Wang ES, Erba H, Zeidan AM, Roboz GJ, Altman JK, Advani AS, Lin TL, Strickland SA, Juckett MB, Pratz KW, Mangan JK, McMahon CM, Alsfeld LC, Balasubramanian SK, Guru Murthy GS, Rotta M, Palmisiano ND, McCloskey J, Saliba AN, Khawandanah M, Madanat YF, Naqvi K, Qasrawi AH, Schiller GJ, Badar T, Gojo I, Yaghmour G, Osman D, Zhang H, Tian Y, Soifer HS, Riches M, Corum D, Leoni M, Fathi AT, Issa GC. Ziftomenib with venetoclax and azacitidine for relapsed/refractory NPM1-mutated acute myeloid leukemia. Blood. 2026 Oct 01; 148(14):1775-1788.

Kim JS, Receveur B, Zhang D, Ma SF, Huang Y, McGroder C, Putman RK, Podolanczuk AJ, Rotter JI, Rich SS, Flaherty KR, Lee JS, Lasky JA, Raghu G, Murray S, Spino C, Martinez FJ, Oh A, Lynch DA, Humphries SM, Adegunsoye A, Oldham JM, Hunninghake GM, Garcia CK, Taub M, Mathias RA, Cho MH, Barr RG, Noth I, Mychaleckyj JC, Manichaikul A, Newton CA. Performance of age-adjusted whole genome sequencing telomere length in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2026 Oct 01; 212(10):2445-2454.

Xanthavanij N, Deshpande R, Yu J, Marchetti N, Garshick E, Blanc PD, Regan EA, Crapo JD, Silverman EK, Wan ES. Occupational exposure to dust and fumes increases risk for future adverse clinical outcomes. Am J Respir Crit Care Med. 2026 Oct 01; 212(10):2618-2627.

Ahmed S, Martín García-Sancho A, Reguera Ortega JL, Cartron G, Rapoport AP, Izutsu K, Ghesquieres H, Goto H, Palomba ML, Abramson JS, Borchmann P, Jäger U, Kamdar M, Dreyling M, Subklewe M, Dahiya S, Nastoupil LJ, Bar M, Strocchia M, Raggi M, Bueno L, Papuga J, Colicino S, Morschhauser F. Durable efficacy and manageable long-term safety of lisocabtagene maraleucel for 3L+ FL: 3-year update from TRANSCEND FL. Blood. 2026 Oct 01; 148(14):1789-1799.

Fakih M, Doi T, Tolcher A, Hong D, Tie J, Messersmith W, Koyama T, Rosen L, Borlido J, Damore MA, Delioukina M, Cheronis I, Clark LN, Golmakani M, Jackson-Fisher A, Tang SY, Guo CC, Keliher EJ, Maresca K, Segal NH. A Phase I Study of PF-07062119, an Anti-GUCY2C/Anti-CD3 Bispecific Fc Antibody, in Patients with Advanced Gastrointestinal Cancers. Cancer Res Commun. 2026 Oct 01; 6(10):2299-2310.

Weaver AN, Keysar SB, Dureja A, Chimed TS, Le PN, Nieto C, Alzofon N, Morton JJ, Thomas CM, Lanning RM, Samedi VG, Van Bokhoven A, Jimeno A. Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes. Cancer Res Commun. 2026 Oct 01; 6(10):2350-2359.

Nicholas LH, Halpern SD, Langa KM, Macis M. Surrogate Decision-Making for Older Adults With and Without Dementia. JAMA Netw Open. 2026 Oct 01; 9(10):e2637691.